Drug Discovery Partnerships

Oxagen seeks collaborations on its GPCR targets where the partner can bring complementary expertise such as synthetic medicinal chemistry to join with Oxagen's inflammation biology and clinical capabilities. Oxagen will adopt a flexible approach to such collaborations including creative approaches such as combining expertise to provide comprehensive offerings to third parties.